Kadomatsu K - Search Results

1

Atelocollagen-mediated systemic delivery prevents immunostimulatory adverse effects of siRNA in mammals.

Inaba S, Nagahara S, Makita N, Tarumi Y, Ishimoto T, Matsuo S, Kadomatsu K, Takei Y. Inaba S, et al. Among authors: kadomatsu k. Mol Ther. 2012 Feb;20(2):356-66. doi: 10.1038/mt.2011.221. Epub 2011 Oct 25. Mol Ther. 2012. PMID: 22031237 Free PMC article.

2

Spatially and temporally regulated expression of N-acetylglucosamine-6-O-sulfotransferase during mouse embryogenesis.

Fan QW, Uchimura K, Yuzawa Y, Matsuo S, Mitsuoka C, Kannagi R, Muramatsu H, Kadomatsu K, Muramatsu T. Fan QW, et al. Among authors: kadomatsu k. Glycobiology. 1999 Sep;9(9):947-55. doi: 10.1093/glycob/9.9.947. Glycobiology. 1999. PMID: 10460836

3

Neointima formation in a restenosis model is suppressed in midkine-deficient mice.

Horiba M, Kadomatsu K, Nakamura E, Muramatsu H, Ikematsu S, Sakuma S, Hayashi K, Yuzawa Y, Matsuo S, Kuzuya M, Kaname T, Hirai M, Saito H, Muramatsu T. Horiba M, et al. Among authors: kadomatsu k. J Clin Invest. 2000 Feb;105(4):489-95. doi: 10.1172/JCI7208. J Clin Invest. 2000. PMID: 10683378 Free PMC article.

4

Syndecan-4 deficiency increases susceptibility to kappa-carrageenan-induced renal damage.

Ishiguro K, Kadomatsu K, Kojima T, Muramatsu H, Matsuo S, Kusugami K, Saito H, Muramatsu T. Ishiguro K, et al. Among authors: kadomatsu k. Lab Invest. 2001 Apr;81(4):509-16. doi: 10.1038/labinvest.3780259. Lab Invest. 2001. PMID: 11304570 Free article.

5

Midkine is involved in neutrophil infiltration into the tubulointerstitium in ischemic renal injury.

Sato W, Kadomatsu K, Yuzawa Y, Muramatsu H, Hotta N, Matsuo S, Muramatsu T. Sato W, et al. Among authors: kadomatsu k. J Immunol. 2001 Sep 15;167(6):3463-9. doi: 10.4049/jimmunol.167.6.3463. J Immunol. 2001. PMID: 11544339

6

Antisense oligodeoxynucleotide targeted to Midkine, a heparin-binding growth factor, suppresses tumorigenicity of mouse rectal carcinoma cells.

Takei Y, Kadomatsu K, Matsuo S, Itoh H, Nakazawa K, Kubota S, Muramatsu T. Takei Y, et al. Among authors: kadomatsu k. Cancer Res. 2001 Dec 1;61(23):8486-91. Cancer Res. 2001. PMID: 11731432

7

5'-,3'-inverted thymidine-modified antisense oligodeoxynucleotide targeting midkine. Its design and application for cancer therapy.

Takei Y, Kadomatsu K, Itoh H, Sato W, Nakazawa K, Kubota S, Muramatsu T. Takei Y, et al. Among authors: kadomatsu k. J Biol Chem. 2002 Jun 28;277(26):23800-6. doi: 10.1074/jbc.M112100200. Epub 2002 Apr 16. J Biol Chem. 2002. PMID: 11959856 Free article.

8

Midkine expression is associated with postnatal development of the lungs.

Matsuura O, Kadomatsu K, Takei Y, Uchimura K, Mimura S, Watanabe K, Muramatsu T. Matsuura O, et al. Among authors: kadomatsu k. Cell Struct Funct. 2002 Apr;27(2):109-15. doi: 10.1247/csf.27.109. Cell Struct Funct. 2002. PMID: 12207052 Free article.

9

Midkine expression in the course of nephrogenesis and its role in ischaemic reperfusion injury.

Sato W, Yuzawa Y, Kadomatsu K, Tayasu T, Muramatsu H, Muramatsu T, Matsuo S. Sato W, et al. Among authors: kadomatsu k. Nephrol Dial Transplant. 2002;17 Suppl 9:52-4. doi: 10.1093/ndt/17.suppl_9.52. Nephrol Dial Transplant. 2002. PMID: 12386288

10

A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics.

Takei Y, Kadomatsu K, Yuzawa Y, Matsuo S, Muramatsu T. Takei Y, et al. Among authors: kadomatsu k. Cancer Res. 2004 May 15;64(10):3365-70. doi: 10.1158/0008-5472.CAN-03-2682. Cancer Res. 2004. PMID: 15150085

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

330 results

Search Page

Filters